{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:58:04Z","timestamp":1784746684984,"version":"3.55.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"DOI":"10.1007\/s11934-026-01338-z","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:41:14Z","timestamp":1776325274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tibial Nerve Stimulation: Recent Progress and Challenges"],"prefix":"10.1007","volume":"27","author":[{"given":"Theodoros","family":"Karanikolas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Aibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Waldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"2","key":"1338_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167\u201378. https:\/\/doi.org\/10.1002\/nau.10052.","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"1338_CR2","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00192-024-06029-2","volume":"36","author":"L Zhang","year":"2025","unstructured":"Zhang L, Cai N, Mo L, Tian X, Liu H, Yu B. Global prevalence of overactive bladder: a systematic review and meta-analysis. Int Urogynecol J. 2025;36(8):1547\u201366. https:\/\/doi.org\/10.1007\/s00192-024-06029-2.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"1338_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.esxm.2019.08.013","volume":"8","author":"G Levy","year":"2020","unstructured":"Levy G, Lowenstein L. Overactive bladder syndrome treatments and their effect on female sexual function: a review. Sex Med. 2020;8(1):1\u20137. https:\/\/doi.org\/10.1016\/j.esxm.2019.08.013.","journal-title":"Sex Med"},{"issue":"12","key":"1338_CR4","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/13696998.2016.1199430","volume":"19","author":"L Ruff","year":"2016","unstructured":"Ruff L, Bagshaw E, Aracil J, Velard M, Pardhanani G, Hepp Z. Economic impact of onabotulinumtoxinA for overactive bladder with urinary incontinence in Europe. J Med Econ. 2016;19(12):1107\u201315. https:\/\/doi.org\/10.1080\/13696998.2016.1199430.","journal-title":"J Med Econ"},{"issue":"1","key":"1338_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/UPJ.0000000000000474","volume":"11","author":"M Pelling","year":"2024","unstructured":"Pelling M, Hammett J, Patil D. Long-term cost analysis of third-line treatment options for overactive bladder. Urol Pract. 2024;11(1):62\u20139. https:\/\/doi.org\/10.1097\/UPJ.0000000000000474.","journal-title":"Urol Pract"},{"issue":"4","key":"1338_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/nau.23477","volume":"37","author":"LC Powell","year":"2018","unstructured":"Powell LC, Szabo SM, Walker D, Gooch K. The economic burden of overactive bladder in the United States: a systematic literature review. Neurourol Urodyn. 2018;37(4):1241\u20139. https:\/\/doi.org\/10.1002\/nau.23477.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"1338_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/JU.0000000000000309","volume":"202","author":"DJ Lightner","year":"2019","unstructured":"Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019. J Urol. 2019;202(3):558\u201363. https:\/\/doi.org\/10.1097\/JU.0000000000000309.","journal-title":"J Urol"},{"issue":"2","key":"1338_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/toxins12020128","volume":"12","author":"CW Lo","year":"2020","unstructured":"Lo CW, Wu MY, Yang SS, Jaw F, Chang S. Comparing the efficacy of onabotulinumtoxinA, sacral neuromodulation, and peripheral tibial nerve stimulation as third-line treatment for the management of overactive bladder symptoms in adults: systematic review and network meta-analysis. Toxins (Basel). 2020;12(2):128. https:\/\/doi.org\/10.3390\/toxins12020128.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"1338_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5694\/mja16.01097","volume":"208","author":"E Chung","year":"2018","unstructured":"Chung E, Lee D, Gani J, Gillman M, Maher C, Brennan J, et al. Position statement: a clinical approach to the management of adult non-neurogenic overactive bladder. Med J Aust. 2018;208(1):41\u20135. https:\/\/doi.org\/10.5694\/mja16.01097.","journal-title":"Med J Aust"},{"issue":"10","key":"1338_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/toxins17100479","volume":"17","author":"MP Roman","year":"2025","unstructured":"Roman MP, Ciortea R, Doumouchtsis SK, M\u0103lu\u021ban AM, Bucuri CE, Ormindean CM, et al. Comparison of different treatment outcomes for refractory overactive bladder: a systematic review and meta-analysis. Toxins (Basel). 2025;17(10):479. https:\/\/doi.org\/10.3390\/toxins17100479.","journal-title":"Toxins (Basel)"},{"issue":"3","key":"1338_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.eururo.2017.11.002","volume":"73","author":"M Tutolo","year":"2018","unstructured":"Tutolo M, Ammirati E, Heesakkers J, Kessler TM, Peters KM, Rashid T, et al. Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature. Eur Urol. 2018;73(3):406\u201318. https:\/\/doi.org\/10.1016\/j.eururo.2017.11.002.","journal-title":"Eur Urol"},{"issue":"3","key":"1338_CR12","first-page":"188","volume":"47","author":"E Wibisono","year":"2015","unstructured":"Wibisono E, Rahardjo HE. Effectiveness of short term percutaneous tibial nerve stimulation for non-neurogenic overactive bladder syndrome in adults: a meta-analysis. Acta Med Indones. 2015;47(3):188\u2013200.","journal-title":"Acta Med Indones"},{"issue":"8","key":"1338_CR13","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/nau.22251","volume":"31","author":"C Burton","year":"2012","unstructured":"Burton C, Sajja A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn. 2012;31(8):1206\u201316. https:\/\/doi.org\/10.1002\/nau.22251.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"1338_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5115\/acb.23.065","volume":"56","author":"AS Soetoko","year":"2023","unstructured":"Soetoko AS, Fatmawati D. Anatomical variations of the tibial nerve and their clinical correlation. Anat Cell Biol. 2023;56(4):415\u201320.","journal-title":"Anat Cell Biol"},{"key":"1338_CR15","unstructured":"Granger CJ, Cohen-Levy WB. In: StatPearls, editor. Anatomy, bony pelvis and lower limb: posterior tibial nerve. Treasure Island (FL): StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546623\/"},{"issue":"3","key":"1338_CR16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.4067\/S0717-95022017000300004","volume":"35","author":"WG Elbarrany","year":"2017","unstructured":"Elbarrany WG, Altaf FM. The tibial nerve and its vasculature: an anatomical evaluation. Int J Morphol. 2017;35(3):812\u20139.","journal-title":"Int J Morphol"},{"issue":"2","key":"1338_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5603\/FM.a2022.0042","volume":"82","author":"A Priya","year":"2023","unstructured":"Priya A, Ghosh SK, Walocha JA, Tubbs RS, Iwanaga J. Variations in the branching pattern of tibial nerve in foot: a review of literature and relevant clinical anatomy. Folia Morphol (Warsz). 2023;82(2):231\u201341.","journal-title":"Folia Morphol (Warsz)"},{"issue":"3","key":"1338_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1590\/S1413-78522012000300005","volume":"20","author":"ALG Torres","year":"2012","unstructured":"Torres ALG, Ferreira MC. Study of the anatomy of the tibial nerve and its branches in the distal medial leg. Acta Ortop Bras. 2012;20(3):157\u201364.","journal-title":"Acta Ortop Bras"},{"issue":"1","key":"1338_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0022-5347(17)42297-X","volume":"139","author":"KP Juenemann","year":"1988","unstructured":"Juenemann KP, Lue TF, Schmidt RA, Tanagho EA. Clinical significance of sacral and pudendal nerve anatomy. J Urol. 1988;139(1):74\u201380.","journal-title":"J Urol"},{"issue":"5","key":"1338_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/0090-4295(90)80078-2","volume":"35","author":"RA Schmidt","year":"1990","unstructured":"Schmidt RA, Senn E, Tanagho EA. Functional evaluation of sacral nerve root integrity: report of a technique. Urology. 1990;35(5):388\u201392.","journal-title":"Urology"},{"issue":"6","key":"1338_CR21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0022-5347(17)42038-6","volume":"140","author":"EA Tanagho","year":"1988","unstructured":"Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. J Urol. 1988;140(6):1331\u20139.","journal-title":"J Urol"},{"issue":"1","key":"1338_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1525-1403.2000.00015.x","volume":"3","author":"MB Chancellor","year":"2000","unstructured":"Chancellor MB, Chartier-Kastler E. Principles of sacral nerve stimulation for the treatment of bladder and urethral sphincter dysfunctions. Neuromodulation. 2000;3(1):15\u201326.","journal-title":"Neuromodulation"},{"issue":"1","key":"1338_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1113\/jphysiol.1976.sp011463","volume":"259","author":"WC De Groat","year":"1976","unstructured":"De Groat WC, Theobald RJ. Reflex activation of sympathetic pathways to vesical smooth muscle and parasympathetic ganglia by electrical stimulation of vesical afferents. J Physiol. 1976;259(1):223\u201337.","journal-title":"J Physiol"},{"issue":"2\u20133","key":"1338_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0006-8993(75)90417-5","volume":"87","author":"WC De Groat","year":"1975","unstructured":"De Groat WC. Nervous control of the urinary bladder of the cat. Brain Res. 1975;87(2\u20133):201\u201311.","journal-title":"Brain Res"},{"issue":"1","key":"1338_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ucl.2004.09.004","volume":"32","author":"WW Leng","year":"2005","unstructured":"Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32(1):11\u20138.","journal-title":"Urol Clin North Am"},{"key":"1338_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1469-445X.1999.tb00080.x","volume":"84","author":"M Craggs","year":"1999","unstructured":"Craggs M, McFarlane J. Neuromodulation of the lower urinary tract. Exp Physiol. 1999;84:149\u201360.","journal-title":"Exp Physiol"},{"key":"1338_CR27","doi-asserted-by":"publisher","first-page":"17042","DOI":"10.1038\/nrdp.2017.42","volume":"3","author":"Y Aoki","year":"2017","unstructured":"Aoki Y, Brown HW, Brubaker L, Cornu JN, Daly JO, Cartwright R. Urinary incontinence in women. Nat Rev Dis Primers. 2017;3:17042.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"1338_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.mpsur.2017.03.002","volume":"35","author":"M Wyndaele","year":"2017","unstructured":"Wyndaele M, Hashim H. Pathophysiology of urinary incontinence. Surg (Oxford). 2017;35(6):287\u201392.","journal-title":"Surg (Oxford)"},{"key":"1338_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn2401","volume":"9","author":"CJ Fowler","year":"2008","unstructured":"Fowler CJ, Griffiths D, De Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9:453\u201366.","journal-title":"Nat Rev Neurosci"},{"key":"1338_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrurol.2015.266","volume":"12","author":"D Griffiths","year":"2015","unstructured":"Griffiths D. Neural control of micturition in humans: a working model. Nat Rev Urol. 2015;12:695\u2013705.","journal-title":"Nat Rev Urol"},{"key":"1338_CR31","doi-asserted-by":"publisher","first-page":"103337","DOI":"10.1016\/j.autneu.2025.103337","volume":"261","author":"PL Dequirez","year":"2025","unstructured":"Dequirez PL, De Wachter S, Biardeau X. Sacral neuromodulation for lower urinary tract dysfunction: overview and mechanisms of action. Auton Neurosci. 2025;261:103337.","journal-title":"Auton Neurosci"},{"issue":"5","key":"1338_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5152\/tud.2021.21152","volume":"47","author":"B Erol","year":"2022","unstructured":"Erol B, Danacioglu YO, Peters KM. Current advances in neuromodulation techniques in urology practices: a review of literature. Turk J Urol. 2022;47(5):375\u201385.","journal-title":"Turk J Urol"},{"issue":"S4","key":"1338_CR33","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1002\/nau.23552","volume":"37","author":"S Malde","year":"2018","unstructured":"Malde S, Fry C, Schurch B, Marcelissen T, Averbeck M, Digesu A, et al. What is the exact working mechanism of botulinum toxin A and sacral nerve stimulation in the treatment of overactive bladder\/detrusor overactivity? ICI-RS 2017. Neurourol Urodyn. 2018;37(S4):S108\u201316. https:\/\/doi.org\/10.1002\/nau.23552.","journal-title":"Neurourol Urodyn"},{"key":"1338_CR34","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s11255-017-1587-x","volume":"49","author":"X Li","year":"2017","unstructured":"Li X, Liao L, Chen G, Wang J, Zhang F, Wang Z, et al. Combination of sacral nerve and tibial nerve stimulation for treatment of bladder overactivity in pigs. Int Urol Nephrol. 2017;49:1139\u201345.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1338_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13063-020-4096-7","volume":"21","author":"JF Padilha","year":"2020","unstructured":"Padilha JF, Avila MA, Seidel EJ, Driusso P. Different electrode positioning for transcutaneous electrical nerve stimulation in the treatment of urgency in women: a study protocol for a randomized controlled clinical trial. Trials. 2020;21(1):166. https:\/\/doi.org\/10.1186\/s13063-020-4096-7.","journal-title":"Trials"},{"key":"1338_CR36","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/nau.23361","volume":"37","author":"A Abulseoud","year":"2018","unstructured":"Abulseoud A, Moussa A, Abdelfattah G, Ibrahim I, Saba E, Hassouna M. Transcutaneous posterior tibial nerve electrostimulation with low dose trospium chloride as second-line treatment of overactive bladder in females. Neurourol Urodyn. 2018;37:842\u20138.","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"1338_CR37","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neurom.2022.04.034","volume":"25","author":"AM Sayner","year":"2022","unstructured":"Sayner AM, Rogers F, Tran J, Jovanovic E, Henningham L, Nahon I, et al. Transcutaneous tibial nerve stimulation in the management of overactive bladder: a scoping review. Neuromodulation. 2022;25(8):1086\u201396.","journal-title":"Neuromodulation"},{"key":"1338_CR38","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00192-012-1691-5","volume":"23","author":"AK Monga","year":"2012","unstructured":"Monga AK, Tracey MR, Subbaroyan J. A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction. Int Urogynecol J. 2012;23:993\u20131005.","journal-title":"Int Urogynecol J"},{"key":"1338_CR39","first-page":"145","volume":"9","author":"LL de Wall","year":"2017","unstructured":"de Wall LL, Heesakkers JP. Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome. Res Rep Urol. 2017;9:145\u201357.","journal-title":"Res Rep Urol"},{"issue":"4","key":"1338_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/MOU.0000000000000781","volume":"30","author":"M Te Dorsthorst","year":"2020","unstructured":"Te Dorsthorst M, van Balken M, Heesakkers J. Tibial nerve stimulation in the treatment of overactive bladder syndrome: technical features of latest applications. Curr Opin Urol. 2020;30(4):513\u20138.","journal-title":"Curr Opin Urol"},{"issue":"7","key":"1338_CR41","doi-asserted-by":"publisher","first-page":"e2265","DOI":"10.1002\/hsr2.2265","volume":"7","author":"SM Maleki","year":"2024","unstructured":"Maleki SM, Heydarpour S, Nikrai R, Heydarpour F. The comparison of effectiveness of acupressure on Spleen 6 and Hugo points on the severity of postpartum pain: a randomized clinical trial. Health Sci Rep. 2024;7(7):e2265. https:\/\/doi.org\/10.1002\/hsr2.2265.","journal-title":"Health Sci Rep"},{"issue":"1","key":"1338_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0022-5347(17)51928-X","volume":"129","author":"EJ McGuire","year":"1983","unstructured":"McGuire EJ, Shi-Chun Z, Horwinski ER, Lytton B. Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol. 1983;129(1):78\u20139.","journal-title":"J Urol"},{"issue":"6","key":"1338_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0090-4295(75)90791-8","volume":"6","author":"C Godec","year":"1975","unstructured":"Godec C, Cass AS, Ayala GF. Bladder inhibition with functional electrical stimulation. Urology. 1975;6(6):663\u20136.","journal-title":"Urology"},{"issue":"6","key":"1338_CR44","doi-asserted-by":"publisher","first-page":"104A","DOI":"10.1016\/S0022-5347(17)75152-X","volume":"137","author":"ML Stoller","year":"1987","unstructured":"Stoller ML, Copeland S, Millard RJ, Murnaghan GF. The efficacy of acupuncture in reversing the unstable bladder in pig-tailed monkeys. J Urol. 1987;137(6):104A.","journal-title":"J Urol"},{"issue":"Suppl 2","key":"1338_CR45","first-page":"16","volume":"35","author":"ML Stoller","year":"1999","unstructured":"Stoller ML. Afferent nerve stimulation for pelvic floor dysfunction. Eur Urol. 1999;35(Suppl 2):16.","journal-title":"Eur Urol"},{"issue":"4","key":"1338_CR46","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S0022-5347(05)66469-5","volume":"165","author":"FE Govier","year":"2001","unstructured":"Govier FE, Litwiller S, Nitti V, Kreder KJ, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165(4):1193\u20138.","journal-title":"J Urol"},{"issue":"7","key":"1338_CR47","doi-asserted-by":"publisher","first-page":"afaf203","DOI":"10.1093\/ageing\/afaf203","volume":"54","author":"DA Vaca-Benavides","year":"2025","unstructured":"Vaca-Benavides DA, Ju W, Gonzalez C, Aitken P, Amma AKN, Mitra S, et al. The importance of electrical parameters on transcutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Age Ageing. 2025;54(7):afaf203. https:\/\/doi.org\/10.1093\/ageing\/afaf203.","journal-title":"Age Ageing"},{"issue":"4","key":"1338_CR48","doi-asserted-by":"publisher","first-page":"499","DOI":"10.32598\/bcn.2023.4896.1","volume":"15","author":"T Ahadi","year":"2024","unstructured":"Ahadi T, Noori I, Soltani SK, Ghaboosi P, Raissi GR. Efficacy of percutaneous vs transcutaneous posterior tibial nerve stimulation in overactive bladder syndrome: a randomized clinical trial. Basic Clin Neurosci. 2024;15(4):499.","journal-title":"Basic Clin Neurosci"},{"key":"1338_CR49","unstructured":"U.S. Food and Drug Administration. Premarket approval (PMA) P200036: eCoin peripheral neurostimulator. 2022."},{"key":"1338_CR50","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000004958","author":"U Lee","year":"2026","unstructured":"Lee U, Xavier K, Carey J, Pickering A, Harris-Hicks J, Giusto L, et al. Implantable tibial neuromodulation therapy improves symptoms of urge urinary incontinence from the TITAN 2 pivotal study. J Urol. 2026. https:\/\/doi.org\/10.1097\/JU.0000000000004958.","journal-title":"J Urol"},{"issue":"3","key":"1338_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5213\/inj.2550162.081","volume":"29","author":"TH Nyan","year":"2025","unstructured":"Nyan TH, Park E. Emerging implantable tibial nerve stimulation devices for overactive bladder. Int Neurourol J. 2025;29(3):146.","journal-title":"Int Neurourol J"},{"issue":"7","key":"1338_CR52","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s12325-024-02864-3","volume":"41","author":"UJ Lee","year":"2024","unstructured":"Lee UJ, MacDiarmid S, Matthews CA, Gillespie E, Peters KM. Tibial nerve stimulation for urge urinary incontinence and overactive bladder: narrative review of randomized controlled trials and applicability to implantable devices. Adv Ther. 2024;41(7):2635\u201354. https:\/\/doi.org\/10.1007\/s12325-024-02864-3.","journal-title":"Adv Ther"},{"key":"1338_CR53","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s11255-021-02999-0","volume":"53","author":"AM Lashin","year":"2021","unstructured":"Lashin AM, Eltabey NA, Wadie BS. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial. Int Urol Nephrol. 2021;53:2459\u201367.","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"1338_CR54","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00192-020-04429-8","volume":"31","author":"M Wang","year":"2020","unstructured":"Wang M, Jian Z, Ma Y, Jin X, Li H, Wang K. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J. 2020;31(12):2457\u201371. https:\/\/doi.org\/10.1007\/s00192-020-04429-8.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"1338_CR55","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.juro.2009.12.036","volume":"183","author":"KM Peters","year":"2010","unstructured":"Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUMIT trial. J Urol. 2010;183(4):1438\u201343. https:\/\/doi.org\/10.1016\/j.juro.2009.12.036.","journal-title":"J Urol"},{"issue":"5","key":"1338_CR56","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.juro.2010.06.113","volume":"184","author":"E Finazzi-Agr\u00f2","year":"2010","unstructured":"Finazzi-Agr\u00f2 E, Petta F, Sciobica F, Pasqualetti P, Musco S, Bove P. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo-controlled trial. J Urol. 2010;184(5):2001\u20136. https:\/\/doi.org\/10.1016\/j.juro.2010.06.113.","journal-title":"J Urol"},{"issue":"21","key":"1338_CR57","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.3390\/jcm12216783","volume":"12","author":"JN Frey","year":"2023","unstructured":"Frey JN, Vidal A, Krebs J, Christmann C. Percutaneous tibial nerve stimulation in the treatment of refractory idiopathic overactive bladder syndrome: a retrospective cohort study. J Clin Med. 2023;12(21):6783. https:\/\/doi.org\/10.3390\/jcm12216783.","journal-title":"J Clin Med"},{"issue":"1","key":"1338_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/2090598X.2019.1590032","volume":"17","author":"C Palmer","year":"2019","unstructured":"Palmer C, Farhan B, Nguyen N, Ghoniem G. Clinical outcomes of percutaneous tibial nerve stimulation in elderly patients with overactive bladder. Arab J Urol. 2019;17(1):10\u20133. https:\/\/doi.org\/10.1080\/2090598X.2019.1590032.","journal-title":"Arab J Urol"},{"issue":"5","key":"1338_CR59","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ajo.13822","volume":"64","author":"HY Kyaw","year":"2024","unstructured":"Kyaw HY, Krause HG, Goh JTW. Percutaneous tibial nerve stimulation for the overactive bladder: a single-arm trial. Aust N Z J Obstet Gynaecol. 2024;64(5):501\u20135. https:\/\/doi.org\/10.1111\/ajo.13822.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8","key":"1338_CR60","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s11255-022-03235-z","volume":"54","author":"R Cava","year":"2022","unstructured":"Cava R, Orlin Y. Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized controlled study. Int Urol Nephrol. 2022;54(8):1825\u201335. https:\/\/doi.org\/10.1007\/s11255-022-03235-z.","journal-title":"Int Urol Nephrol"},{"issue":"20","key":"1338_CR61","doi-asserted-by":"publisher","first-page":"e25941","DOI":"10.1097\/MD.0000000000025941","volume":"100","author":"DY Yang","year":"2021","unstructured":"Yang DY, Zhao LN, Qiu MX. Treatment for overactive bladder: a meta-analysis of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation. Med (Baltim). 2021;100(20):e25941. https:\/\/doi.org\/10.1097\/MD.0000000000025941.","journal-title":"Med (Baltim)"},{"issue":"9","key":"1338_CR62","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00345-018-2296-5","volume":"36","author":"PA Leroux","year":"2018","unstructured":"Leroux PA, Brassart E, Lebdai S, Azzouzi AR, Bigot P, Carrouget J. Transcutaneous tibial nerve stimulation: 2-year follow-up outcomes in the management of anticholinergic-refractory overactive bladder. World J Urol. 2018;36(9):1455\u201360. https:\/\/doi.org\/10.1007\/s00345-018-2296-5.","journal-title":"World J Urol"},{"issue":"1","key":"1338_CR63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/nau.24554","volume":"40","author":"I Ram\u00edrez-Garc\u00eda","year":"2020","unstructured":"Ram\u00edrez-Garc\u00eda I, Kauffmann S, Blanco-Ratto L, Carralero-Mart\u00ednez A, S\u00e1nchez E. Patient-reported outcomes in a randomized control trial comparing transcutaneous versus percutaneous stimulation of the posterior tibial nerve in idiopathic overactive bladder syndrome. Neurourol Urodyn. 2020;40(1):295\u2013302. https:\/\/doi.org\/10.1002\/nau.24554.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"1338_CR64","doi-asserted-by":"publisher","first-page":"101486","DOI":"10.1016\/j.rehab.2021.101486","volume":"65","author":"R Sonmez","year":"2022","unstructured":"Sonmez R, Yildiz N, Alkan H. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: a prospective randomised controlled trial. Ann Phys Rehabil Med. 2022;65(1):101486. https:\/\/doi.org\/10.1016\/j.rehab.2021.101486.","journal-title":"Ann Phys Rehabil Med"},{"issue":"10","key":"1338_CR65","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/iju.14961","volume":"29","author":"MS Alomari","year":"2022","unstructured":"Alomari MS, Abdulhamid AS, Ghaddaf AA, Alshareef KM, Haneef AK, AlQuhaibi MS, et al. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: a systematic review and meta-analysis. Int J Urol. 2022;29(10):1170\u201380. https:\/\/doi.org\/10.1111\/iju.14961.","journal-title":"Int J Urol"},{"issue":"6","key":"1338_CR66","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/bju.16330","volume":"133","author":"L Liao","year":"2024","unstructured":"Liao L, Li X, Chong T, Chen Q, Xu Z, Huang B, et al. Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder. BJU Int. 2024;133(6):760\u2013769. https:\/\/doi.org\/10.1111\/bju.16330","journal-title":"BJU Int."},{"issue":"4","key":"1338_CR67","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/nau.25421","volume":"43","author":"A Kapur","year":"2024","unstructured":"Kapur A, Aalami Harandi A, Hartman-Kenzler J, Kim J. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator. Neurourol Urodyn. 2024;43(4):959\u2013966. https:\/\/doi.org\/10.1002\/nau.25421","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"1338_CR68","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/17434440.2023.2254678","volume":"20","author":"MJ Bressington","year":"2023","unstructured":"Bressington MJ, Scholtz D, Hooshiary A, Vermeulen W, Burns T, Ordones F, et al. Device evaluation: eCoin \u2013 implantable tibial nerve stimulator for overactive bladder. Expert Rev Med Devices. 2023;20(11):899\u2013904. https:\/\/doi.org\/10.1080\/17434440.2023.2254678.","journal-title":"Expert Rev Med Devices"},{"issue":"3","key":"1338_CR69","doi-asserted-by":"publisher","first-page":"e81121","DOI":"10.7759\/cureus.81121","volume":"17","author":"V Lucente","year":"2025","unstructured":"Lucente V, Morrisroe S, Schiff W, Barber N. A prospective study on the effectiveness of sensory and sub-sensory stimulation amplitudes using eCoin implantable tibial nerve stimulation in reducing urgency urinary incontinence episodes and enhancing quality of life. Cureus. 2025;17(3):e81121. https:\/\/doi.org\/10.7759\/cureus.81121.","journal-title":"Cureus"},{"key":"1338_CR70","doi-asserted-by":"publisher","unstructured":"Sutherland SE, Heesakkers JPFA, Ferrante KL, Dmochowski RR. Impact of Revi\u00ae implantable tibial neuromodulation on quality of life in patients with urgency urinary incontinence. Int Urogynecol J. 2026;23. https:\/\/doi.org\/10.1007\/s00192-026-06538-2","DOI":"10.1007\/s00192-026-06538-2"},{"issue":"3","key":"1338_CR71","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/JU.0000000000004328","volume":"213","author":"JPFA Heesakkers","year":"2024","unstructured":"Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, Digesu A, Amundsen CL, McCrery RJ, et al. Two-year efficacy and safety outcomes of the pivotal OASIS study using the REVI system for treatment of urgency urinary incontinence. J Urol. 2024;213(3):323\u201332. https:\/\/doi.org\/10.1097\/JU.0000000000004328.","journal-title":"J Urol"},{"issue":"1","key":"1338_CR72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12325-024-03019-0","volume":"42","author":"CL Amundsen","year":"2025","unstructured":"Amundsen CL, Sutherland SE, Kielb SJ, Dmochowski RR. Sacral and implantable tibial neuromodulation for the management of overactive bladder: a systematic review and meta-analysis. Adv Ther. 2025;42(1):10\u201335. https:\/\/doi.org\/10.1007\/s12325-024-03019-0.","journal-title":"Adv Ther"},{"issue":"4","key":"1338_CR73","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00192-021-05030-3","volume":"33","author":"KS Kopcsay","year":"2022","unstructured":"Kopcsay KS, Marczak TD, Jeppson PC, Cameron AP, Khavari R, Tefera E, et al. Treatment of refractory overactive bladder with onabotulinumtoxinA vs PTNS: TROOP trial. Int Urogynecol J. 2022;33(4):851\u201360. https:\/\/doi.org\/10.1007\/s00192-021-05030-3.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"1338_CR74","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/nau.24944","volume":"41","author":"K Kapriniotis","year":"2022","unstructured":"Kapriniotis K, Jenks J, Toia B, Pakzad M, Gresty H, Stephens R, et al. Does response to percutaneous tibial nerve stimulation predict similar outcome to sacral nerve stimulation? Neurourol Urodyn. 2022;41(5):1172\u20136. https:\/\/doi.org\/10.1002\/nau.24944.","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"1338_CR75","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00192-018-3834-9","volume":"30","author":"G Rostaminia","year":"2018","unstructured":"Rostaminia G, Chang C, Pincus JB, Sand PK, Goldberg RP. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome. Int Urogynecol J. 2018;30(10):1735\u201345. https:\/\/doi.org\/10.1007\/s00192-018-3834-9.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"1338_CR76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2490-13-61","volume":"13","author":"G Gaziev","year":"2013","unstructured":"Gaziev G, Topazio L, Iacovelli V, Asimakopoulos A, Di Santo A, De Nunzio C, et al. Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urol. 2013;13(1):61. https:\/\/doi.org\/10.1186\/1471-2490-13-61.","journal-title":"BMC Urol"},{"issue":"1","key":"1338_CR77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/nau.70183","volume":"45","author":"A Shatkin-Margolis","year":"2025","unstructured":"Shatkin-Margolis A, Crow A, Wang L, Nseyo U, Walter LC, Covinsky KE, et al. Utilization of more than one minimally invasive overactive bladder therapy among older adults: a national Medicare study. Neurourol Urodyn. 2025;45(1):145\u201354. https:\/\/doi.org\/10.1002\/nau.70183.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"1338_CR78","first-page":"209","volume":"81","author":"K Propst","year":"2017","unstructured":"Propst K, Butler H, O\u2019Sullivan DM, Tunitsky-Bitton E. Peripheral tibial nerve stimulation for overactive bladder syndrome: treatment success and patient satisfaction. Conn Med. 2017;81(4):209\u201313.","journal-title":"Conn Med"},{"issue":"8","key":"1338_CR79","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00192-018-3822-0","volume":"30","author":"S Iyer","year":"2018","unstructured":"Iyer S, Laus K, Rugino A, Botros C, Lozo S, Botros SM, et al. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder. Int Urogynecol J. 2018;30(8):1253\u20139. https:\/\/doi.org\/10.1007\/s00192-018-3822-0.","journal-title":"Int Urogynecol J"},{"issue":"6","key":"1338_CR80","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/nau.70088","volume":"44","author":"FA Jefferson","year":"2025","unstructured":"Jefferson FA, Hanson KT, Khan AA, Gebhart JB, Elliott DS, Linder BJ. Patterns of care following procedural intervention among women with overactive bladder. Neurourol Urodyn. 2025;44(6):1332\u20138. https:\/\/doi.org\/10.1002\/nau.70088.","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"1338_CR81","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/biomedicines11071931","volume":"11","author":"SA Stalder","year":"2023","unstructured":"Stalder SA, Van Der Lely S, Anderson CE, Birkh\u00e4user V, Curt A, Gross O, et al. Development of a sham protocol to investigate transcutaneous tibial nerve stimulation in randomized, sham-controlled, double-blind clinical trials. Biomedicines. 2023;11(7):1931. https:\/\/doi.org\/10.3390\/biomedicines11071931.","journal-title":"Biomedicines"},{"key":"1338_CR82","unstructured":"BlueWind M. Revi System: Important Safety Information [Internet]. BlueWind Medical; [cited 2026 Mar 3]. Available from: https:\/\/bluewindmedical.com\/important-safety-information\/"},{"issue":"1","key":"1338_CR83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003985","volume":"212","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ, Enemchukwu E, Ginsberg DA, Helfand BT, et al. The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024;212(1):11\u201320. https:\/\/doi.org\/10.1097\/JU.0000000000003985.","journal-title":"J Urol"},{"issue":"4","key":"1338_CR84","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5213\/inj.1836246.123","volume":"22","author":"E Park","year":"2018","unstructured":"Park E, Lee J, Kang M, Cho K, Cho BH, Lee K. Detecting bladder biomarkers for closed-loop neuromodulation: a technological review. Int Neurourol J. 2018;22(4):228.","journal-title":"Int Neurourol J"},{"issue":"1","key":"1338_CR85","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1038\/s41467-025-59436-4","volume":"16","author":"Y Lim","year":"2025","unstructured":"Lim Y, Kim JH, Kim J, Hoang M, Kang W, Koh M, et al. Precise control of tibial nerve stimulation for bladder regulation via evoked compound action potential feedback mechanisms. Nat Commun. 2025;16(1):4115. https:\/\/doi.org\/10.1038\/s41467-025-59436-4.","journal-title":"Nat Commun"},{"issue":"2","key":"1338_CR86","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.neurom.2023.07.002","volume":"27","author":"C Goudelocke","year":"2024","unstructured":"Goudelocke C, Nikolas LMJ, Bittner KC, Offutt SJ, Miller AE, Slopsema JP. Sensing in sacral neuromodulation: a feasibility study in subjects with urinary incontinence and retention. Neuromodulation. 2024;27(2):392\u20138.","journal-title":"Neuromodulation"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-026-01338-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:41:20Z","timestamp":1776325280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-026-01338-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1007\/s11934-026-01338-z","relation":{},"ISSN":["1534-6285"],"issn-type":[{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Nitya Abraham is chair of the data safety monitoring board for Ecoin. The additional authors declare no conflicts of interest, financial or otherwise, for this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}